Laryxin Menthol

Chlorhexidine dihydrochloride and lidocaine hydrochloride, the active ingredients in Laryxin Menthol, are an antiseptic and a local anesthetic presented as an oromucosal solution for topical use. They provide antimicrobial action and temporary pain relief for patients with sore throat, mouth ulcers, oral mucosal infections or other irritation of the oropharynx.

GNH USA supplies Laryxin Menthol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laryxin Menthol acts on oral mucosal conditions to reduce infection and pain.

Sore throat: alleviates pain and reduces microbial load in the pharynx. Mouth ulcers: provides local anaesthesia and antiseptic protection to promote comfort. Oral mucosal infections: helps control bacterial growth while numbing the affected area. Irritation of the oropharynx: eases discomfort and prevents secondary infection.

Laryxin Menthol may cause a range of adverse reactions.

Common Side Effects: - Altered taste sensation. - Mild oral irritation or burning. - Transient numbness of the mouth. - Temporary discoloration of the mucosa. - Mild headache. - Slight dryness of the oral cavity.

Serious or Rare Side Effects: - Allergic reactions such as angioedema or anaphylaxis. - Severe mucosal ulceration or necrosis. - Prolonged numbness or systemic lidocaine toxicity. - Rare dermatologic events like Stevens‑Johnson syndrome.

Before using Laryxin Menthol, consider the following precautions.

Avoid use in individuals with known hypersensitivity to chlorhexidine or lidocaine. Do not apply to extensive oral lesions without medical supervision. Limit duration of use to the period prescribed by a healthcare professional. Monitor for signs of allergic reaction, such as rash or swelling. Use caution in patients with cardiac conduction disorders due to potential systemic lidocaine absorption. Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Laryxin Menthol may interact with other medications.

Major Interactions (Avoid): - Concurrent use with other topical anesthetics may increase systemic lidocaine levels. - Simultaneous application of additional chlorhexidine‑containing products can cause additive mucosal irritation.

Moderate Interactions (Monitor Closely): - Use with alcohol‑based mouthwashes may reduce antiseptic efficacy. - Patients on anticoagulant therapy should be observed for increased bleeding if mucosal lesions occur. - Caution when combined with systemic lidocaine‑containing drugs (e.g., antiarrhythmics) due to additive toxicity risk.